Outlook Therapeutics, Inc. · NASDAQ:OTLK

GMS VENTURES & INVESTMENTS reported a 41.60% stake in Outlook Therapeutics, Inc. (Schedule 13D/A)

Event Mar 11, 2025 · Filed Mar 12, 2025

GMS VENTURES & INVESTMENTS reported a 41.60% stake in Outlook Therapeutics, Inc., 16,183,187 shares, with active intent on Mar 11, 2025. Filed Mar 12, 2025 (Schedule 13D/A).

Stake
41.60%
Shares
16,183,187
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
GMS VENTURES & INVESTMENTS41.60%16,183,187
SUKHTIAN GHIATH M.41.60%16,183,787

Source

View original at SEC

Related